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Background: Edible plants such as Cratoxylum formosum (Jack) Dyer, Curcumin longa Lin, Momordica charantia Lin
and Moringa oleifera Lam have long been believed in Thai culture to relieve ulcers and the symptoms of liver
disease. However, little is known about their anti-liver cancer properties and antiviral activity against hepatitis B virus
(HBV). The aim of this study was to investigate the anti-liver cancer and anti-HBV activities of crude extracts from
these edible plants on human liver cancer cells.
Methods: Plant samples were prepared and extracted using buffer and hydro-alcoholic solvents. The MTT assay
was performed to investigate the effects of the plant extracts on the cell viability of HepG2 cells. The inhibitory
effect on replication of HBV was analysed by determining the level of HBV covalently closed circular DNA (cccDNA)
in transiently transfected HepG2 cells with the DNA expression plasmid of the HBV genome using a quantitative
real-time PCR.
Results: Buffer and hydroalcoholic extracts from C. formosum (leaf) reduced cell viability of HepG2 cells and they
also inhibited HBV cccDNA. Crude extracts from C. longa (bulb) in both solvents did not have any cytotoxic effects
on the HepG2 cells, but they significantly decreased the level of HBV cccDNA. Buffer extracts from the leaves of
M. charantia and the fruits of M. oleifera showed to have anti-HBV activity and also a mild cytotoxicity effect on the
HepG2 cells. In addition, leaves of M. Oleifera extracted by hydroalcoholic solvent drastically decreased the level of
cccDNA in transiently transfected HepG2 cells.
Conclusion: Some crude extracts of edible plants contain compounds that demonstrate anti-liver cancer and
anti-HBV activities.
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Hepatitis B virus (HBV) infection is a major global
health problem that can cause liver cirrhosis and liver
cancer. Although the HBV vaccination can effectively
prevent new infections, current HBV antiviral drugs are
reported to have adverse effects on patients or promote
the development of drug-resistance [1]. Therefore, novel
antiviral drugs and alternative treatments are urgently
needed for millions of people that are chronically* Correspondence: fscinnp@ku.ac.th
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reproduction in any medium, provided the orinfected with HBV. Currently, much attention has been
focused on dietary factors that reduce the risk of cancers
[2]. Natural products or phytonutrients appear to be po-
tent therapeutics for viral diseases and cancers [3-5].
A number of edible plants in Thailand have been trad-
itionally used to cure illness. For example, the roots and
leaves of Cratoxylum formosum (Jack) Dyer can be used
in a diuretic based diet that may relieve symptoms of
liver cirrhosis. Bulbs of Curcumin longa Lin has been
consumed to treat stomach ulcers and is believed to help
prevent liver cancer [6]. The pods and leaves of Moringa
oleifera Lam have been taken orally to fight cancers and
control inflammation. The fruits and leaves ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cure symptoms of liver diseases [7]. In addition, several
studies have confirmed the medical properties of these
edible plants. For example, curcumin extracted from C.
longa has been reported to have anti-inflammatory and
antioxidant properties and shows antiviral activity for
HBV and hepatitis C virus [8-10]. Oil and emulsion
extractions from leaves from C. formosum have been
reported to have high antioxidant activity [11]. 70%
methanol extraction of bark from C. formosum has been
demonstrated to have diuretic effects [12]. Fruit extracts
of M. charantia have displayed anticancer and antiviral
activities against HIV and herpes virus [13,14]. Extracts
of M. oleifera has shown to inhibit the replication of
herpes virus and Epstein-Barr virus [15,16]. Nonetheless,
the anti-liver cancer and anti-HBV properties of C. for-
mosum, M. charantia and M. oleifera have not yet been
investigated.
This study therefore investigated inhibitory effects of
crude extracts from C. formosum, M. charantia and M.
oleifera on the viability of human liver cancer cells
(HepG2) and their antiviral activity against the replica-
tion of the template of HBV transcription (Covalently
closed circular DNA or cccDNA). C. longa hot water ex-
tract was included in this study as the positive control
for the anti-HBV property.
Methods
Preparation of plant materials
Four edible Thai plants, C. longa, C. formosum, M. char-
antia and M. oleifera were purchased from a local mar-
ket in Bangkok. The plants were dried under shade for
3 weeks and grounded into powder and stored at 4°C
until further use. The powder was then extracted by two
different solvent systems, the first being a 80% hydroal-
coholic solvent (80% ethanol and 20% distilled water)
and the second, a 50 mM Tris-HCl buffer (pH 7.5). For
hydroalcoholic extraction, samples were shaken in 80%
hydroalcoholic solvent for 16 h at room temperature.
Then, the solutions were filtered, and then the filtrate
was re-suspended and shaken in ethanol for 48 h. All
extracts were pooled, re-filtered and concentrated using
a rotary evaporator and then lyophilized. Prior to testing,
the lyophilized extracts were dissolved in distilled water
to produce 1 g/L of plant extracts. The extract yield (%,
w/w) was determined from all hydroalcoholic extracts by
using the formula:
Yield %ð Þ
¼ The weight of extract after lyophilisation of solvent 100ð Þ
The weight of the plant powder
(Additional file 1: Table S1).For buffer extraction, the samples were incubated in
buffer for 48 h at 4°C in the dark, filtered, and then cen-
trifuged at high speed for 30 min at 4°C. The super-
natant of each sample was collected and dialysed in
Tris-HCl for 48 h, then total protein was determined
using the Bradford assay, using BSA as a protein stand-
ard. The total protein of each buffer extract is presented
in Additional file 1: Table S1.
Cell culture and transfection
Both COS-7 and HepG2 (ATCC, gifts from The Centre
of Excellence Clinical Virology and Molecular Biology
Research, Chulalongkorn University) were cultured in
DMEM (Gibco, Invitrogen) and supplemented with
10% (v/v) heat inactivated fetal bovine serum (Gibco,
Invitrogen) and 1%(v/v) antimicotic antibiotic (Gibco,
Invitrogen). All cell lines were cultured in 75 cm3 ster-
ile tissue culture flasks at 37°C under a 5% CO2 atmos-
phere. For quantitative real time-PCR, HepG2 cells
were seeded on 24-well plates with approximately
1 x 105 cells in each well. Seeded cells were treated
with either 30 μg/mL of hydroalcoholic crude extracts
or buffer extracts containing 0.3 μg total protein and
then transfected with 1 μg of the DNA expression
plasmid of HBV genome (pHBV48, a gift from M-H
Lin, National Taiwan University) [17] and using the
Lipofectamine™ 2000 in triplicate. This plasmid has
been reported to express full-length HBV and is able to
produce HBV particles in cells [17]. For the positive
control, cells were transfected with 1 μg of pHBV48
without addition of crude extracts. The ratio between
Lipofectamine™ 2000 (μL) and DNA (μg) was 3:1. After
5 days of incubation, cells were subjects to DNA
extraction and real-time analysis.
Cell viability assay (MTT assay)
COS-7 and HepG2 cells were seeded on 96-well
plates with a cell density of approximately 1.5x 103
cells per 150 μL of media in each well. After 24 h of
incubation, cells were added with 0 (solvent only), 50,
150 and 300 μg/mL of hydroalcoholic extracts. For
buffer extracts, cells were incubated with 0 (buffer
only), 0.5, 1, 1.5 and 2 μg of total protein extracts
from each plant. A cell-free control was also included
to exclude any false positive results from the assay
[18]. Each sample was performed in quadruplicate
and cells were incubated for 3, 5 and 7 days. After
incubation, the culture medium was removed from
each well by aspiration and 4 μg of MTT (Invitrogen)
was added into each well. After 3 h of incubation,
DMSO (Amresco) was added to dissolve the purple
formazan of MTT. The absorbance was then mea-
sured by a microplate reader at a wavelength of
Waiyaput et al. BMC Complementary and Alternative Medicine 2012, 12:246 Page 3 of 7
http://www.biomedcentral.com/1472-6882/12/246570 nm. The cell viability (%) was calculated using
the formula:Absorbance of test compound Absorbance of cell free controlð Þ
Absorbance of cell without treatment Absorbance of cell free controlð Þ  100Quantitative real time- PCR analysis of HBV cccDNA
Total DNAs were isolated from each well using a gen-
omic DNA Extraction mini kit (RBC Bioscience) accord-
ing to the manufacturer’s instruction. HBV cccDNA was
amplified and quantified by real-time PCR assay using
specific primers: HBV_CCC_F1 (50- actcttggactccag
caatg-30) and HBV_CCC_R1 (50-ctttatacgggtcaatgtcca-30)
with SYBR-green. These pair of primers was designed to
match the region corresponding to the gap and incom-
plete region in the partially double- stranded HBV DNA.
Therefore, they specifically amplify DNA fragments
from HBV cccDNA but not from genomic DNA [19].
Negative control (no DNA template) was included to de-
termine contamination whereas the positive control
(transfected cells with 1 μg of pHBV48) was performed
to yield quantitative information. Each sample was per-
formed in triplicate. A result was indicated in terms of a
relative quantitation by the comparative threshold
(delta-delta Ct) method, (2-ΔΔCt). In this study, the refer-
ence gene was beta-globin. The target gene was the
cccDNA of transfected HBV and the calibrator was cells
transfected with only the HBV plasmid.
Statistical analysis
Student’s t-test [20] was used for comparing data be-
tween control cells (COS-7) and human liver cancer
(HepG2) cells in the viability assay. It also used to deter-
mine significant differences between the positive control
(transfected cells with pHBV48 without addition of
crude extracts) and treated cells with crude extracts in














n1  1ð ÞS21 þ n2  1ð ÞS22
 
n1 þ n2  2
X and X2 are means of % cell viability of COS-7 cells
and HepG2 cells respectively; Sp is the sample standard
deviation (uncertainty value); S1
2 is COS-7 sample vari-
ance; S2
2 is HepG2 sample variance; n1 is number of
COS-7 sample and n2 is number of HepG2 sample.
The t distribution was used with the degree of freedom(df ) = n1 + n2 -2. A p-value was determined from the
probability table [20]. A P value < 0.05 indicated the
presence of a statistically significant difference.Results and discussion
Effects of crude extracts on the viability of HepG2 cells
To examine whether extracts from tested edible Thai
plants could inhibit the viability of liver cancer cells, an
optimisation of the MTT assay was performed on the
non-cancerous cell (COS-7) for evaluating: (i) the appro-
priate concentration of crude extract needed such that
there was no cytotoxic effects on the normal cells, (ii)
the amount of MTT compound needed and (iii) the dur-
ation of effects. We used hot water extracts of C. longa
as our analytical control because its cytotoxicity and
anti-HBV activity were previously reported on the liver-
cancer cells [9]. Subsequently, COS-7 cells were treated
with various concentrations of C. longa hot water extract
(100-900 μg/mL) and different amounts of MTT
(2-8 μg) and then the MTT assay was performed after 3,
5 and 7 days post-incubation. A high variation of cell
viability was observed when cells were treated with 8 μg
of MTT while using 2 μg of MTT produced an unclear
pattern of dose dependent effects at any time setting
(Figure 1). At day 5, the cytotoxicity effect of C. longa
extract was moderately elevated in a dose dependent
manner with 4 μg of MTT and the concentrations of
extracts at higher than 300 μg/mL drastically affected
cell viability (less than 65% of cell viability, Figure 1B).
At day 7, the inhibitory effect was absent and most of
the cells were found to be unhealthy when viewed under
a microscope leading to relatively high variation of data
(Figure 1C). Therefore, the appropriate amount of MTT
was 4 μg and the optimal concentration of C. longa hot
water extract that had no effect on the normal cells was
less than 300 μg/mL. The best inhibitory effect was
observed at day 5. These optimal conditions were used
when analysing the inhibitory effects of all crude extracts
on COS-7 and HepG2 cells. The data analysed at day 5
were shown as bar graphs in Figure 2 (see supplemental
information for the actual numbers of percentage of cell
viability, Additional file 1: Table S2).
From Figure 2A, our data indicated that 50 and
150 μg/mL of hot water extracts from the bulbs of C.
longa could specifically affect cell viability of HepG2.
However, Kim et al. (2009) reported that 500 μg/mL of
C. longa hot water extract had no cytotoxicity effect on
the same kind of cell. This variation of concentration
may be due to the different conditions used for the
MTT assay. Interestingly, crude extract of C. longa by
Figure 1 Optimisation experiment of MTT assay on COS-7 cells.
Cells were treated with various concentrations of C. longa hot water
extract as indicated in quadruplicate. After 3 days (A); 5 days (B); and
7 days (C) of incubation, cells were subjected to viability analysis
using MTT assay with different amounts of MTT (2-8 μg). Bar graph
represents a mean value whereas an error bar indicates the
uncertainty value of three independent experiments.
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cells (Figure 2B). This result may suggest that proteins
are not involved in the inhibitory effects. Nonetheless,
higher amount of total protein may be needed to con-
firm the MTT result of C. longa buffer extract. Curcu-
min is the product obtained by solvent extraction of C.longa and is known to have anti-liver cancer activity
[21]. However, our result showed that cytotoxicity effect
of 80% hydro-alcoholic C. longa crude extract on HepG2
cells had no significant differences from the COS-7 cells
(Figure 2C). Therefore, the higher concentration of C.
longa 80% ethanol extraction may be required to have
an effect on the cells.
For the buffer extracts, the results indicated that 0.5
μg of total protein extraction from leaves of C. formosum
significantly decreased cell viability of the HepG2 cells
without affecting cell viability of COS-7 cells (Figure 2B:
p < 0.001). A similar observation was found for 2 μg of
total protein extraction from the leaves of M. charantia
and the fruits of M. oleifera (Figure 2B: p < 0.01 and
0.001 respectively). However, higher amounts of protein
extracts from the leaves of C. formosum seemed to have
a greater cytotoxic effect on normal cells than the
HepG2 cells. Up to now, there has not been a report on
biological active peptides or hepatoprotective proteins
from the extraction of C. formosum. Therefore, it is very
interesting to examine novel peptides or a proteomic
profile of C. formosum buffer extract. In addition, the
crude extract of C. formosum leaves by 80% ethanol dis-
played a significant difference of inhibitory effect be-
tween the HepG2 and COS-7 cells (Figure 2C: p <
0.001). This effect is likely due to chlorogenic acid, dicaf-
feoylquinic acid and ferulic acid derivatives that are
previously reported to play important roles in the antic-
ancer activity of C. formosum [11]. Notably, crude
extracts by 80% ethanol from the fruits and leaves of M.
charantia and M. oleifera did not significantly inhibit
cell viability of HepG2 cells (Figure 2C). Therefore, the
MTT results (Figure 2) suggested that the crude extracts
of C. formosum are shown to have the best cytotoxicity
effect against liver cancer cells whereas hydroalcoholic
extracts of M. oleifera (fruit and leaf ) and M. charantia
(fruit and leaf ) do not contain compounds that act spe-
cifically against the anti-liver cancer activity.
Some crude extracts of edible plants that could
significantly decrease the level of HBV cccDNA in
HepG2 cells
To study the effect of crude extracts on the replication
of HBV, the level of HBV transcription template
(cccDNA) was determined using quantitative real-time
PCR. This experiment included C. longa hot water ex-
tract as the analytical control and we found that the ex-
tract significantly inhibited cccDNA of HBV with 85%
inhibition (data not shown). This result was consistent
with the previous report indicating that C. longa hot
water extract has anti-HBV activity [9]. In addition, al-
most all the buffer extracts (0.3 μg of total protein) sig-
nificantly decreased the level of HBV cccDNA in
transiently transfected HepG2 cells with the DNA
Figure 2 (See legend on next page.)
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Figure 2 The cytotoxicity effects from plant extracts on COS-7 and HepG2 cells. (A) The effect from hot water extract of C. longa (bulb),
(B) The effects from buffer extracts and (C) The effects from 80% hydroalcoholic extracts. The white bars represent the percentage of cell viability
of COS-7 cells whereas the black bars represent the percentage of cell viability of HepG2 cells. Bar graph represents a mean value whereas an
error bar indicates the uncertainty value of three independent experiments. “*” and “**” indicated significant inhibitory effect when compared
with both cell lines at p < 0.01 and p < 0.001 (by t-test) respectively.
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inhibition from the buffer extractions was observed in C.
longa (bulb), C. formosum (leaf ) and M.oleifera (leaf )
with about 80% inhibition whereas M. oleifera (fruit)
showed to have a moderate inhibitory effect with about
50% inhibition. Notably, buffer extracts from the fruits
and leaves of M. Charantia were found to drastically re-
duce gene expression of the reference gene (beta-globin)
when compared with untreated cells, thus we did
not analyse their effects on the level of HBV cccDNA
(Figure 3). This is the first report on the anti-HBV activ-
ity of crude extracts by the buffer method from C. longa
(bulb), C. formosum (leaf ) and M.oleifera (leaf ). Further
experiments will be carried out to investigate any poten-
tial anti-HBV compounds from these plant extracts in-
cluding their mechanism inside the cells.
Furthermore, our results suggest that 30 μg/mL aque-
ous ethanol extracts of M. olifera (fruit) and C. longa
(bulb) drastically decreased the level of HBV cccDNA
with greater than 85% inhibition. The 30 μg/mL hydroal-
coholic extracts of C. formosum (leaf ) and M. Charantia
(leaf ) also showed a moderate inhibition of the level of
HBV cccDNA with 50% inhibition. Hence, our resultsFigure 3 Effects of crude extracts on the level of cccDNA in transient
HBV genome. HepG2 cells were treated with either 30 μg/mL of hydroalc
1 μg of the DNA expression plasmid of HBV genome using Lipofectamine
well was extracted and subjected for quantitative real-time analysis. Bar gra
uncertainty value of three independent experiments. “*” and “**” indicate s
p < 0.01 and p < 0.001 (by t- test) respectively. “F” is for fruit and “L” is for lesuggested that crude extracts from 80% ethanol of C.
longa (bulb), C. formosum (leaf ), M. olifera (fruit) and
M. Charantia (leaf ) contain compounds that could in-
hibit HBV replication. On the other hand, 30 μg/mL
ethanol extracts of M. Charantia (fruit) and M. olei-
fera (leaf ) had no effect on the level of HBV cccDNA
(Figure 3). Therefore, the M. oleifera (leaf ) ethanol
extracts have antiviral activities against herpes simplex
virus type 1 (HSV-1) [15] and Sindbis virus [22], but
not HBV.
Conclusion
In this study, we provided the first report on the cyto-
toxicity effect against liver cancer cell and anti-HBV
activity from crude extracts of C. formosum (leaf ) by
using 80% ethanol and Tris-HCl solvents. A mild cyto-
toxicity effect on HepG2 cells was also observed with
the buffer extracts of M. charatia (leaf ) and M. olei-
fera (fruit), and the hydroalcoholic extracts of these
plants were also able to inhibit HBV cccDNA. These
results are promising and are to be followed with fur-
ther analysis of isolated phytochemicals and proteins
from these extracts including the identification of thely transfected HepG2 cells with the DNA expression plasmid of
oholic extracts or 0.3 μg of buffer extracts and were transfected with
™ 2000 in triplicate. After 5 days of incubation, the total DNA of each
ph represents a mean value whereas an error bar indicates the
ignificant inhibitory effect when compared with the positive cccDNA at
af.
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nents in these plant extracts.Additional file
Additional file 1: Table S1. The extract yield (%, w/w) of hydroalcoholic
extracts and total protein of buffer extracts. Table S2. Effects of crude
extracts on the cell viability of COS-7 and HepG2 cells.
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